The FDA has granted accelerated approval to two Alzheimer’s drugs so far. Eli Lilly’s amyloid plaque-busting therapy won’t become the third. The Lilly drug still has a chance to pass regulatory muster, but it will take more data and more time.
Lilly announced the complete response letter…
Source: medcitynews.com – Read more
Information of 38,000 UChicago medical group patients potentially exposed in cybersecurity breach
Around 38,000 patients of UChicago Medicine’s medical group may have had their personal data revealed in a cybersecurity breach. The breach occurred in July through